Published in Tissue Eng Part A on December 10, 2012
Origin, development, and differentiation of cardiac fibroblasts. J Mol Cell Cardiol (2013) 1.03
Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs. Tissue Eng Part A (2014) 0.89
Induced pluripotent stem cells for regenerative medicine. Annu Rev Biomed Eng (2014) 0.88
Electrical stimulation as a biomimicry tool for regulating muscle cell behavior. Organogenesis (2013) 0.85
Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells. Biochem Biophys Res Commun (2013) 0.83
Cardiac cell culture model as a left ventricle mimic for cardiac tissue generation. Anal Chem (2013) 0.80
The use of a novel cardiac bioreactor system in investigating fibroblast physiology and its perspectives. Organogenesis (2013) 0.76
It's all in the timing: modeling isovolumic contraction through development and disease with a dynamic dual electromechanical bioreactor system. Organogenesis (2014) 0.76
Electrical and mechanical stimulation of cardiac cells and tissue constructs. Adv Drug Deliv Rev (2015) 0.76
"The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells. Exp Biol Med (Maywood) (2015) 0.75
Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs. Crit Rev Biomed Eng (2015) 0.75
Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells (2004) 4.79
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52
Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol (2012) 2.71
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation (2012) 2.58
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation (2005) 2.15
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77
Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovasc Res (2006) 1.62
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol (2005) 1.61
Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res (2009) 1.58
Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. J Mol Cell Cardiol (2003) 1.54
Electrophysiological properties of human mesenchymal stem cells. J Physiol (2003) 1.53
A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol (2011) 1.53
Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods (2008) 1.52
Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.49
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol (2005) 1.47
Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol (2005) 1.43
Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury. J Control Release (2013) 1.40
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol (2005) 1.37
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis (2011) 1.33
Adult zebrafish heart as a model for human heart? An electrophysiological study. J Mol Cell Cardiol (2009) 1.29
Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs. Nat Immunol (2006) 1.26
Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev (2006) 1.21
Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol (2004) 1.21
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21
Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol (2003) 1.20
A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials (2009) 1.19
Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. J Physiol (2013) 1.17
Therapy and prophylaxis of Ebola virus infections. Curr Opin Investig Drugs (2005) 1.16
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res (2002) 1.15
Dynamic alterations of fibronectin layers on copolymer substrates with graded physicochemical characteristics. Langmuir (2004) 1.14
Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments. Nat Methods (2013) 1.14
A practical guide to quantify cell adhesion using single-cell force spectroscopy. Methods (2013) 1.12
In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials (2005) 1.10
Smart skin patterns protect springtails. PLoS One (2011) 1.09
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol (2008) 1.09
Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials (2009) 1.09
Aligned fibrillar collagen matrices obtained by shear flow deposition. Biomaterials (2008) 1.08
Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation (2002) 1.07
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res (2007) 1.06
Cardiac mechano-electric feedback: past, present, and prospect. Prog Biophys Mol Biol (2003) 1.06
Fibronectin displacement at polymer surfaces. Langmuir (2005) 1.05
Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. J Thorac Cardiovasc Surg (2005) 1.05
Flow-dependent regulation of angiopoietin-2. J Cell Physiol (2008) 1.05
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Gene-expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells (2005) 1.04
FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials (2010) 1.02
Maleic anhydride copolymers--a versatile platform for molecular biosurface engineering. Biomacromolecules (2003) 1.02
Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart. Br J Pharmacol (2009) 1.02
Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone (2010) 1.02
Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res (2007) 1.01
Engineered matrix coatings to modulate the adhesion of CD133+ human hematopoietic progenitor cells. Biomaterials (2006) 1.01
Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol (2009) 1.01
Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]. Mol Pharmacol (2006) 1.01
Caveolin-1 opens endothelial cell junctions by targeting catenins. Cardiovasc Res (2011) 1.00
Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs). Biochem Biophys Res Commun (2009) 1.00
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J (2009) 1.00
Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res (2005) 0.98
Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. Eur J Pharmacol (2007) 0.96
Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells. Biochem Biophys Res Commun (2009) 0.96
Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells (2012) 0.96
The growth and differentiation of mesenchymal stem and progenitor cells cultured on aligned collagen matrices. Biomaterials (2009) 0.96
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J (2009) 0.96
Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem (2009) 0.95
Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus. Chembiochem (2006) 0.95
Thermo-responsive PNiPAAm-g-PEG films for controlled cell detachment. Biomacromolecules (2003) 0.95
A novel, low-volume method for organ culture of embryonic kidneys that allows development of cortico-medullary anatomical organization. PLoS One (2010) 0.95
Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha. Mol Biol Cell (2010) 0.95
Modulated fibronectin anchorage at polymer substrates controls angiogenesis. Tissue Eng (2004) 0.94
Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J Pharmacol Exp Ther (2008) 0.94
Tissue distribution of a human Ca v 1.2 alpha1 subunit splice variant with a 75 bp insertion. Cell Calcium (2005) 0.94
Characterization of polymer membranes by MALDI mass-spectrometric imaging techniques. Anal Chem (2013) 0.94
Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials (2012) 0.94
Fibronectin anchorage to polymer substrates controls the initial phase of endothelial cell adhesion. J Biomed Mater Res A (2003) 0.94
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Hematopoietic stem and progenitor cells in adhesive microcavities. Integr Biol (Camb) (2009) 0.94
Cholinergic and purinergic responses in isolated human detrusor in relation to age. J Urol (2005) 0.94
The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res (2013) 0.93
Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor. J Cardiovasc Pharmacol (2013) 0.93
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest (2014) 0.93
In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage. Arthritis Res Ther (2009) 0.93
Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. Future Cardiol (2009) 0.93
Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha. EMBO Rep (2010) 0.93
Nanoscale features of fibronectin fibrillogenesis depend on protein-substrate interaction and cytoskeleton structure. Biophys J (2004) 0.93
In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces. Biomaterials (2007) 0.92
The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol (2010) 0.92
Adsorption-induced conformational changes of proteins onto ceramic particles: differential scanning calorimetry and FTIR analysis. J Colloid Interface Sci (2006) 0.91
5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res (2006) 0.89
Immobilization of growth factors on solid supports for the modulation of stem cell fate. Nat Protoc (2010) 0.89
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. Br J Pharmacol (2005) 0.88